Iguratimod in Systemic Sclerosis

NCT04515706 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis, Diffuse

Interventions

DRUG: Iguratimod
DRUG: Placebo

Sponsor

RenJi Hospital